Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy.
Purevjav E, Nelson DP, Varela JJ, Jimenez S, Kearney DL, Sanchez XV, DeFreitas G, Carabello B, Taylor MD, Vatta M, Shearer WT, Towbin JA, Bowles NE.
Purevjav E, et al. Among authors: kearney dl.
Cardiovasc Toxicol. 2007;7(4):255-63. doi: 10.1007/s12012-007-9004-9. Epub 2007 Oct 18.
Cardiovasc Toxicol. 2007.
PMID: 17943461